Hospital service and logistics robotics in China covers a wider operational footprint than any other medical robot category, reflecting the scale and throughput pressure of Chinese tertiary hospitals (many with 2000+ beds and 10,000+ daily outpatient visits). The segment spans inpatient material delivery (medications, specimens, consumables — Noah, AiBayes, YouXiMei, TMiRob Delivery, Intelligent Delivery Robot), pneumatic tube systems as a non-robotic but widely co-deployed alternative (TransLogic, HongFengShu Aerial), outpatient guidance and reception (Keenon, ChuangChuang, FuBo, Cruzr, BellaBot, HolaBot), nuclear medicine handling (TMiRob Nuclear), and warehouse/pharmacy logistics (HaiPick, HikRobot, Quicktron, Lynx).
Operationally, autonomous mobile robots (AMRs) in Chinese hospitals benefit from newer building stock with wider corridors and more standardized elevator integration, which made multi-robot fleets operational earlier than in many legacy Western hospital environments. Vendors typically bundle fleet-management software with physical robots, and integration with hospital logistics IT and access control is now a de facto requirement rather than optional.
Regulatory treatment varies: service and guidance robots generally do not fall under NMPA device regulation, while nuclear medicine handling and specimen delivery carrying biohazard or radioactive material face specific handling requirements. For manufacturers, the Chinese hospital AMR market is unusual in combining high unit volumes at large individual sites with purchasing processes that emphasize integration and total cost of ownership over single-robot pricing.
See data methodology for how this listing is maintained.